The safety and long-term efficacy of zonisamide as adjunctive therapy for focal epilepsy

References

• Baulac M, Brodie MJ, Patten A, et al. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine in newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurol 2012;11:579-88
   PubMed Web of Science ®Google Scholar
• Glauser T, Ben-Menachem E, Bourgeous B, et al. Updated ilae evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013;54:551-63
   PubMed Web of Science ®Google Scholar
• Schulze-Bonhage A. Zonisamide in the treatment of epilepsy. Expert Opin Pharmacol 2010;11:115-26
   PubMed Web of Science ®Google Scholar
• Zaccara G, Specchio LM. Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature. Neuropsychiatr Dis Treat 2009;5:249-59
   PubMed Web of Science ®Google Scholar
• Gaitatzis A, Sander JW. The long-term safety of antiepileptic drugs. CNS Drugs 2013;27:435-55
   PubMed Web of Science ®Google Scholar
• Marson AG, Al-Kharusi AM, Alwaidh M, et al. The sanad study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1000-15
   PubMed Web of Science ®Google Scholar
• Marson AG, Al-Kharusi AM, Alwaidh M, et al. The sanad study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1016-26
   PubMed Web of Science ®Google Scholar
• Peters DH, Sorkin EM. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs 1993;5:760-87
   Google Scholar
• Kawai M, Hiramatsu M, Endo A, et al. Effect of zonisamide on release of aspartic acid and gamma-aminobutyric acid from hippocampal slices of E1 mice. Neurosciences 1994;20:115-19
   Google Scholar
• Ueda Y, Doi T, Tokumaru J, et al. Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures. Brain Res Mol Brain Res 2003;116(1-2):1-6
   PubMedGoogle Scholar
• Schauf CL. Zonisamide enhances slow sodium inactivation in myxicola. Brain Res 1987;413:185-8
   PubMed Web of Science ®Google Scholar
• Suzuki S, Kawakami K, Nishimura S, et al. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res 1992;12:21-7
   PubMed Web of Science ®Google Scholar
• Okada M, Hirano T, Kawata Y, et al. Biphasic effects of zonisamide on serotonergic system in rat hippocampus. Epilepsy Res 1999;2-3.187-97
   Google Scholar
• Okada M, Kaneko S, Hirano T, et al. Effects of zonisamide on dopaminergic system. Epilepsy Res 1995;3:193-205
   Google Scholar
• Komatsu M, Okamura Y, Hiramatsu M. Free radical scavenging activity of zonisamide and its inhibitory effect on lipid peroxide formation in iron-induced epileptogenic foci of rats. Neurosciences 1995;21:23-9
   Web of Science ®Google Scholar
• Masuda Y, Karasawa T. Inhibitory effect of zonisamide on human carbonic anhydrase in vitro. Arzneimittelforschung 1993;4:416-18
   Google Scholar
• Thone J, Leniger T, Splettstosser F, et al. Antiepileptic activity of zonisamide on hippocampal CA3 neurons does not depend on carbonic anhydrase inhibition. Epilepsy Res 2008;2-3:105-11
   Google Scholar
• Yamauchi T, Aikawa H. Efficacy of zonisamide: our experience. Seizure 2004;13(S1):41-8
   Google Scholar
• Sills G, Brodie M. Pharmacokinetics and drug interactions with zonisamide. Epilepsia 2007;3:435-41
   Google Scholar
• Wagner JG, Sackellares JC, Donofrio PD, et al. Nonlinear pharmacokinetics of CI-912 in adult epileptic patients. Ther Drug Monit 1984;6:277-83
   PubMedGoogle Scholar
• Leppik IE. Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure 2004;13(S1):5-9
   Google Scholar
• Frampton JE, Scott LJ. Zonisamide. a review of its use in the management of partial seizures in epilepsy. CNS Drugs 2005;19(4):347-67
   Google Scholar
• Odani A, Hashimoto Y, Takayanagi K, et al. Population pharmacokinetics of phenytoin in japanese patients with epilepsy: analysis with a dose-dependent clearance model. Biol Pharm Bull 1996;3:444-8
   Google Scholar
• Ragueneau-Majlessi I, Levy RH, Bergen D, et al. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. Epilepsy Res 2004;1-1:11
   Google Scholar
• Levy RH, Ragueneau-Majlessi I, Brodie MJ, et al. Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patientes with epilepsy. Ther Drug Monit 2005;2:193-8
   Google Scholar
• Ragueneau-Majlessi I, Levy RH, Brodie M, et al. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy. Clin Pharmacokinet 2005;5:517-23
   Google Scholar
• Minami T, Ieiri I, Ohtsubo K, et al. Influence of additional therapy with zonisamide (excegran) on protein binding and metabolism of carbamazepine. Epilepsia 1994;35:1023-5
   PubMed Web of Science ®Google Scholar
• McJilton J, De Toledo J, DeCerce J. Cotherapy of lamotrigine/zonisamide results in significant elevation of zonisamide levels. Epilepsia 1996;37(S5)):173
   Google Scholar
• Baulac M, Patten A, Giorgi L. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: Results of a phase III, randomized, double-blind study. Epilepsia 2014;55:1534-43
   PubMed Web of Science ®Google Scholar
• Wroe SJ, Yeates AB, Marshall A. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy. Acta Neurol Scand 2008;118:87-93
   PubMed Web of Science ®Google Scholar
• Shinnar S, Pellok JM, Conry JA. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Eur J Ped Neurol 2009;13:3-9
   PubMed Web of Science ®Google Scholar
• Guerrini R, Rosati A, Bradshaw K, Giorgi L. Adjunctive ZNS therapy in the long-term treatment of children with partial apilepsy: results of an open-label extension study of a phase III, randomized, double-blind placebo-controlled trial. Epilepsia 2014;5:568-78
   Google Scholar
• Kim DW, Choi K, Moon HS, Oh J. Long-term retention rate of Zonisamide in patients with epilepsy: an observational study. Clin Neuropharm 2014;37:133-5
   PubMed Web of Science ®Google Scholar
• Wellmer J, Wellmer S, Bauer J. The impact of zonisamide on weight. a clinical study in 103 patients with epilepsy. Acta Neurol Scand 2009;119:233-8
   PubMedGoogle Scholar
• Lim J, Ko Y-H, Joe S-H, et al. Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(8):1918-21
   Google Scholar
• Lee YJ, Kang HC, Seo JH, et al. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy. Brain Dev 2010;32(3):208-12
   PubMed Web of Science ®Google Scholar
• Zaccara G, Specchio LM. Long-term safety and effectiveness of zonisamid in the treatment of epilepsy: a review oft he literature. Neuropsychiatr Dis Treat 2009;5:249-59
   PubMed Web of Science ®Google Scholar
• Ozawa K, Kobayashi K, Noda S, Iyo M. Zonisamide-induced depression and mania in patients with epilepsy. J Clin Psychopharmacol 2004;24(1):110-1
   PubMed Web of Science ®Google Scholar
• Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 2007;30(7):555-67
   PubMed Web of Science ®Google Scholar
• Cavanna AE, Seri S. Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities. Epilepsy Behav 2013;29(2):281-4
   Web of Science ®Google Scholar
• Fornaro M, Martino M, Dalmasso B, et al. An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects. Ann Gen Psychiatry 2011;10(1):23
   Google Scholar
• Brodie MJ. Zonisamide clinical trials: european experience. Seizure 2004;13(1):66-70
   Google Scholar
• Leppik I, Willmore L, Homan R, et al. Efficacy and safety of zonisamide in pediatric patientes with epilepsy. Epilepsy Res 1993;14:165-73
   PubMed Web of Science ®Google Scholar
• Leppik IE. Practical prescribing and long-term efficacy and safety of zonisamide. Epilepsy Res 2006;68(S2):17-24
   Google Scholar
• Brodie MJ, Kelly K, Stephen LJ. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses? Epil Behav 2014;31:3-76
   Google Scholar